The main pathological feature of IBD is transmural infiltration of polymorphonuclear neutrophils and MPO is released from these neutrophils.[16, 17] Treatment with AEFB significantly decreased the level of MPO compared to the model group which shows that AEFB decreases the infiltration of the inflammatory cells which are responsible for the increasing the progression of the disease condition. This evidence concerns the gene MPO and inflammatory bowel disease.